Abiopharma

1stDibs to Participate in Upcoming Investor Conference

CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results

Zoetis - Zoetis Receives Emergency Use Authorization for SimparicaTrio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

Barings Participation Investors Reports Preliminary Second Quarter 2026 Results and Announces Quarterly Cash Dividend Of $0.37 Per Share

Barings Corporate Investors Reports Preliminary Second Quarter 2026 Results and Announces Quarterly Cash Dividend Of $0.40 Per Share

Harvey Authement, Jr. Joins First Horizon Bank As Banking Center Manager In Houma

EXPANDED CLASS PERIOD - Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Pentair plc (PNR) Shareholders To Inquire About Securities Fraud Class Action

Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights